Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

5.00%

8.4¢ percheron therapeutics limited

Yeah for sure, not suggesting for a second that ANP aren’t...

First 25 Last

Share
Profile

Follow
raisinsareheresy

206 Posts.

62

28/09/21

18:25

Post #: 56413761
Share

Originally posted by lonade: ↑

"ANP have maintained that they intend to be supplementary in the DMD therapeutics market rather than as direct competitors to companies like Sarepta, Santhera etc"

@shyaam1996 as a small biotech company you do not want to upset the big players by stating that "our treatment will replace the likes of Sarepta, Santhera etc..." if you are at the late stage development phase then you are looking for big players to inject their money into your treatment.

so it would be unwise to upset these players with unrealistic and inappropriate statements ....once commercialized, the market will then decide how often and when to utilize the ANP treatment.

but as always, if your son had DMD would you want them to use the one with the best results or any of the others....

Expand

Yeah for sure, not suggesting for a second that ANP aren’t intending to compete with or out perform existing therapies available for DMD. My point is that their therapeutic approach is one of a couple that companies have taken to treat DMD. So far as I have seen, AT1102 appears to be the most effective and generalised treatment to date, however I welcome people to provide insights into therapies offered by those other than ANP and Sarepta.

ANP Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

World Gold Council says market in want of catalyst; flags Asia sell-off risks. Then there's Trump

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

SS1

Sun Silver to kick off drilling next week at 292Moz Maverick Springs silver-gold project

AHK

Ark Mines inks 1.5Bt Exploration Target for Sandy Mitchell REE play including NdPr; PFS due in Q4

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

There are more pages in this discussion • 7 more messages in this thread...

First 25 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.4¢		Change 0.004(5.00%)		Mkt cap ! $75.72M

Open	High	Low	Value	Volume
8.0¢	8.4¢	8.0¢	$26.89K	328.0K

Buyers (Bids)

No.	Vol.	Price($)
1	9602	8.3¢

Sellers (Offers)

Price($)	Vol.	No.
8.4¢	58051	1

View Market Depth

No.	Vol.	Price($)
1	9602	0.083
1	5500	0.082
1	75000	0.081
2	85000	0.080
2	27150	0.079

Price($)	Vol.	No.
0.084	58051	1
0.085	106431	2
0.086	100000	1
0.087	125000	1
0.089	135000	2

Last trade - 16.10pm 03/07/2024 (20 minute delay)

PER (ASX) Chart

SPONSORED BY